Saba, N. F., Ismaila, N., Worden, F., Beadle, B. M. (2026). Reply to: Therapeutic Strategy Concerns for
                    <i>BRAF</i>
                    V600E–Mutated Differentiated Thyroid Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01611